Economic Evaluations of mHealth Interventions for the Management of Type 2 Diabetes: A Scoping Review
Authors' conclusion
The current literature indicates that mHealth interventions for type 2 diabetes can be cost-saving or cost-effective, however, the quality of the reporting can be substantially improved. Heterogeneity makes it difficult to compare study outcomes, and the failure to report on key items leaves insufficient information for decision-makers to consider.
Study context
- Population
- Full and partial economic evaluation studies of mHealth interventions for T2D, five databases, January 2007 to March 20229 full, 3 partial economic evaluation (EEs)
- Participants
- 12 participants
- Outcome
- Economic evaluations of mHealth for T2D
Methodological detailsReporting of full EEs appraised with the CHEERS 2022 checklist
- Reporting of full EEs appraised with the CHEERS 2022 checklist
Main finding
As reported in the abstract
Median CHEERS score (reporting quality mostly moderate)
59%
Original publication
Economic Evaluations of mHealth Interventions for the Management of Type 2 Diabetes: A Scoping Review. J Diabetes Sci Technol. Published 3 July 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →